Postchallenge responses of nitrotyrosine and TNF-alpha during 75-g oral glucose tolerance test are associated with the presence of coronary artery diseases in patients with prediabetes

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Chu, Chih Sheng ^a,b,c,d   Lee, Kun Tai ^a,b   Cheng, Kai Hong ^a,b,d   Lee, Min Yi ^d   Kuo, Hsuan Fu ^c,d   Lin, Tsung Hsien ^a,b   Su, Ho Ming ^a,b   Voon, Wen Chol ^a,b   Sheu, Sheng Hsiung ^a,b   Lai, Wen Ter ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

^c KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Coronary artery disease; Glucose tolerance test; Inflammation; Nitrotyrosine oral; Oxidative stress; Postchallenge hyperglycemia

Indexed keywords

3 NITROTYROSINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; 3-NITROTYROSINE; AUTACOID; BIOLOGICAL MARKER; DRUG DERIVATIVE; IL6 PROTEIN, HUMAN; TYROSINE;

ADULT; ALCOHOL CONSUMPTION; ANGIOCARDIOGRAPHY; ARTICLE; BIOCHEMISTRY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; ENZYME IMMUNOASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POSTCHALLENGE HYPERGLYCEMIA; PREDICTOR VARIABLE; RISK ASSESSMENT; SMOKING; AGED; BLOOD; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; RISK; RISK FACTOR; STATISTICAL MODEL; TAIWAN; TIME;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDIABETIC STATE; RISK ASSESSMENT; RISK FACTORS; TAIWAN; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

EID: 84857762022     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-21     Document Type: Article

References (35)

1. Kannel WB, McGee DL. Diabetes and cardiovascular diseases: the Framingham study. JAMA 1979, 241:2035-2038. 10.1001/jama.1979.03290450033020, 430798.
2. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999, 22:233-240. 10.2337/diacare.22.2.233, 10333939.
3. Ceriello A. Impaired glucose tolerance and cardiovascular disease: the possible role of post-prandial hyperglycemia. Am Heart J 2004, 147:803-807. 10.1016/j.ahj.2003.11.020, 15131534.
4. Ceriello A, Esposito K, Piconi L, Ihnat M, Thorpe J, Testa R, Bonfigli AR, Giugliano D. Glucose "peak" and glucose "spike": impact on endothelial function and oxidative stress. Diabetes Res Clin Pract 2008, 82:262-267. 10.1016/j.diabres.2008.07.015, 18950890.
5. The DECODE study group Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe. Lancet 1999, 354:617-621. The DECODE study group.
6. Rodriguez BL, Lau N, Burchfiel CM, Abbott RD, Sharp DS, Yano K, Curb JD. Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care 1999, 22:1262-1265. 10.2337/diacare.22.8.1262, 10480768.
7. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
8. Lebovitz HE. Effect of the postprandial state on nontraditional risk factors. Am J Cardiol 2001, 88:20H-25H.
9. Heine RJ, Dekker JM. Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabetologia 2002, 45:461-475. 10.1007/s00125-001-0726-0, 12032622.
10. Haffner SM. The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. Endocr Rev 1998, 19:583-592. 10.1210/er.19.5.583, 9793758.
11. Biondi-Zoccai GG, Abbate A, Liuzzo G, Biasucci LM. Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol 2003, 41:1071-1077. 10.1016/S0735-1097(03)00088-3, 12679203.
12. Mathew M, Tay E, Cusi K. Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activaition, myeloperoxidase and PAI-1 in healthy subjects. Cardiovasc Diabetol 2009, 9:9.
13. Sanchez R, Fischer P, Cuniberti L, Masnatta LD, Ramirez AJ. Vascular oxidative stress is associated with insulin resistance in hyper-reninemic nonmodulating essential hypertension. J Hypertens 2007, 25:2434-2440. 10.1097/HJH.0b013e3282f03597, 17984665.
14. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072. 10.1161/01.CIR.0000034509.14906.AE, 12379575.
15. Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Boil Chem Hoppe Seyler 1994, 375:81-88.
16. Horvath EM, Magenheim R, Kugler E, Vacz G, Szigethy A, Levardi F, Kollai M, Szabo C, Lacza Z. Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies. Diabetologia 2009, 52:1935-1943. 10.1007/s00125-009-1435-3, 19597800.
17. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 2001, 44:834-838. 10.1007/s001250100529, 11508267.
18. Shishehbor MH, Aviles RJ, Brennan ML, Fu X, Goormastic M, Pearce GL, Gokce N, Keaney JF, Penn MS, Sprecher DL, Vita JA, Hazen SL. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 2003, 289:1675-1680. 10.1001/jama.289.13.1675, 12672736.
19. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003, 26:3160-3167. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
20. Hoffmeister A, Rothenbacher D, Bazner U, Frohlich M, Brenner H, Hombach V, Koenig W. Role of novel markers of inflammation in patients with stable coronary heart disease. Am J Cardiol 2001, 87:262-266. 10.1016/S0002-9149(00)01355-2, 11165957.
21. Taubert G, Winkelmann BR, Schleiffer T, Marz W, Winkler R, Gok R, Klein B, Schneider S, Boehm BO. Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 2003, 145:285-291. 10.1067/mhj.2003.134, 12595846.
22. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002, 359:2140-2144. 10.1016/S0140-6736(02)09089-X, 12090978.
23. Satoh H, Terada H, Uehara A, Katoh H, Matsunaga M, Yamazaki K, Matoh F, Hayashi H. Post-challenge hyperinsulinaemia rather than hyperglycaemia is associated with the severity of coronary artery disease in patients without a previous diagnosis of diabetes mellitus. Heart 2005, 91:731-736. 10.1136/hrt.2003.032326, 1768918, 15894763.
24. Hosseinpanah F, Rambod M, Reza Ghaffari HR, Azizi F. Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS). Diabet Med 2006, 23:982-989. 10.1111/j.1464-5491.2006.01939.x, 16922704.
25. Hashimoto K, Ikewaki K, Yagi H, Nagasawa H, Imamoto S, Shibata T, Mochizuki S. Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes. Diabetes Care 2005, 28:1182-1186. 10.2337/diacare.28.5.1182, 15855586.
26. Kanauchi M, Tsujimoto N, Hashimoto T. Advanced glycation end products in nondiabetic patients with coronary artery disease. Diabetes Care 2001, 24:1620-1623. 10.2337/diacare.24.9.1620, 11522709.
27. Takezako T, Saku K, Zhang B, Shirai K, Arakawa K. Insulin resistance and angiographical characteristics of coronary atherosclerosis. Jpn Circ J 1999, 63:666-673. 10.1253/jcj.63.666, 10496480.
28. Festa A, D'Agostino R, Tracy RP, Haffner SM. C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study. Diabet Med 2002, 19:939-943. 10.1046/j.1464-5491.2002.00824.x, 12421431.
29. Johansen OE, Birkeland KI, Brustad E, Aaser E, Lindahi AK, Midha R, Ueland T, Aukrus P, Gullestad L. Undiagnosed dysglycaemia and inflammation in cardiovascular disease. Eur J Clin Invest 2006, 36:544-551. 10.1111/j.1365-2362.2006.01679.x, 16893376.
30. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102:42-47.
31. Lu B, Yang Y, Yang Z, Feng X, Wang X, Zhang Z, Hu R. Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity. Cardiovasc Diabetol 2010, 9:92. 10.1186/1475-2840-9-92, 3020174, 21167068.
32. Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Esposito K, Giugliano D. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 2004, 53:701-710. 10.2337/diabetes.53.3.701, 14988255.
33. Dinh W, Futh R, Nickl W, Krahn T, Ellinghaus P, Scheffold T, Bansemir L, Bufe A, Barroso MC, Lankisch M. Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc Diabetol 2009, 8:58. 10.1186/1475-2840-8-58, 2778641, 19909503.
34. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin-6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA 2001, 286:2107-2113. 10.1001/jama.286.17.2107, 11694151.
35. Oberbach A, Tonjes A, Kloting N, Fasshauer M, Kratzsch J, Bussee MW, Paschke R, Stumvoll M, Bluher M. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J endocrinol 2006, 154:577-585. 10.1530/eje.1.02127, 16556721.